508 related articles for article (PubMed ID: 20660402)
1. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG
N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402
[TBL] [Abstract][Full Text] [Related]
2. Molecular Analysis of Goodpasture's Disease Following Hematopoietic Stem Cell Transplant in a Pediatric Patient, Recalls the Conformeropathy of Wild-Type Anti-GBM Disease.
Gray PE; McCarthy H; Siggs OM; Saleem MA; O' Brien T; Frith K; Ziegler JB; Kitching AR; Fogo AB; Hudson BG; Pedchenko V
Front Immunol; 2019; 10():2659. PubMed ID: 31798588
[No Abstract] [Full Text] [Related]
3. Quaternary epitopes of α345(IV) collagen initiate Alport post-transplant anti-GBM nephritis.
Olaru F; Luo W; Wang XP; Ge L; Hertz JM; Kashtan CE; Sado Y; Segal Y; Hudson BG; Borza DB
J Am Soc Nephrol; 2013 May; 24(6):889-95. PubMed ID: 23620401
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
[TBL] [Abstract][Full Text] [Related]
5. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
7. Goodpasture's disease--new secrets revealed.
Salant DJ
N Engl J Med; 2010 Jul; 363(4):388-91. PubMed ID: 20660408
[No Abstract] [Full Text] [Related]
8. Autoepitopes and alloepitopes of type IV collagen: role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis.
Borza DB
Nephron Exp Nephrol; 2007; 106(2):e37-43. PubMed ID: 17570938
[TBL] [Abstract][Full Text] [Related]
9. The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain.
Kang JS; Kashtan CE; Turner AN; Heidet L; Hudson BG; Borza DB
J Biol Chem; 2007 Apr; 282(14):10670-7. PubMed ID: 17293596
[TBL] [Abstract][Full Text] [Related]
10. Alport alloantibodies but not Goodpasture autoantibodies induce murine glomerulonephritis: protection by quinary crosslinks locking cryptic α3(IV) collagen autoepitopes in vivo.
Luo W; Wang XP; Kashtan CE; Borza DB
J Immunol; 2010 Sep; 185(6):3520-8. PubMed ID: 20709951
[TBL] [Abstract][Full Text] [Related]
11. Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis.
Pedchenko V; Vanacore R; Hudson B
Curr Opin Nephrol Hypertens; 2011 May; 20(3):290-6. PubMed ID: 21378566
[TBL] [Abstract][Full Text] [Related]
12. An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies.
Charytan D; MacDonald B; Sugimoto H; Pastan S; Staton G; Hennigar R; Kalluri R
Am J Kidney Dis; 2005 Apr; 45(4):743-8. PubMed ID: 15806477
[TBL] [Abstract][Full Text] [Related]
13. The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: characterization of the antibody target.
vd Heuvel LP; Schröder CH; Savage CO; Menzel D; Assmann KJ; Monnens LA; Veerkamp JH
Pediatr Nephrol; 1989 Oct; 3(4):406-13. PubMed ID: 2642109
[TBL] [Abstract][Full Text] [Related]
14. Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains.
Borza DB; Bondar O; Todd P; Sundaramoorthy M; Sado Y; Ninomiya Y; Hudson BG
J Biol Chem; 2002 Oct; 277(42):40075-83. PubMed ID: 12193605
[TBL] [Abstract][Full Text] [Related]
15. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
Brainwood D; Kashtan C; Gubler MC; Turner AN
Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
[TBL] [Abstract][Full Text] [Related]
16. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
[TBL] [Abstract][Full Text] [Related]
17. Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane nephritis in rats.
Luo AM; Fox JW; Chen L; Bolton WK
J Lab Clin Med; 2002 May; 139(5):303-10. PubMed ID: 12032491
[TBL] [Abstract][Full Text] [Related]
18. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
[TBL] [Abstract][Full Text] [Related]
19. Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers.
Olaru F; Wang XP; Luo W; Ge L; Miner JH; Kleinau S; Geiger XJ; Wasiluk A; Heidet L; Kitching AR; Borza DB
J Immunol; 2013 Feb; 190(4):1424-32. PubMed ID: 23303673
[TBL] [Abstract][Full Text] [Related]
20. Laminin, fibronectin, and Goodpasture antigen detection in patients with Alport's syndrome.
Basta-Jovanovic G; Savin M; Jovanovic AZ; Veljovic R; Sindjic M
Ren Fail; 1993; 15(4):503-8. PubMed ID: 8210562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
